Skip to content
healthcare.dev

Levetiracetam

NDC 66993-101, levetiracetam, tablet, for suspension, from Prasco Laboratories.

Product NDC
66993-101
Status
Listed
Labeler
Prasco Laboratories
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA207958
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66993-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVETIRACETAM500 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
66993-101-606699301016060 BLISTER PACK in 1 CARTON (66993-101-60) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66993-101-51)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dd175fa3-1d7a-4542-affd-988ac5bba1db

Use it

Look up 66993-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66993-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66993-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.